retatrutide mechanism triple agonist glp-1 gip glucagon The Road towards Agonists: Glucagon-Like Peptide 1, Glucose-Dependent Insulinotropic Polypeptide and Receptor What are the mechanisms of

Diabetes Care 41(9):19811990

12 Another key area of regulatory focus in FY25 compared to prior years includes the crackdown on promotional communications

Dual GIP & GLP-1 Agonists While Single GLP-1 RAs focus on one incretin pathway (the GLP-1 pathway), Dual GIP and GLP-1 agonists double down by also acting on another pathway involved in glucose regulation and energy balance

So the upward line from semaglutide to tirzepatide to retatrutide is best read as a hypothesis strongly supported by early evidence, not as a law guaranteeing that triple agonism will end up strictly superior once the full safety and durability picture is in

The pharmaceutical industry has spent decades trying to develop effective treatments for fatty liver disease